Morning Overview on MSN
A Harvard scientist says his team is preparing the first human trials aimed at reversing aging
A team linked to Harvard Medical School has dosed the first patient in a clinical trial designed to reverse cellular aging in ...
For the first time ever, scientists are attempting to reverse cellular aging in a living patient. The target: incurable ...
Paper in Cloning and Stem Cells shows that animal eggs do not support specific reprogramming toward the normal human embryonic state. Investigators at Advanced Cell Technology (ACTC) have found that ...
Scientists have taken a small but significant step toward testing the idea of reverse aging in humans. Researchers have ...
Life Biosciences says it just dosed its first patient in an FDA-approved clinical trial to reverse age-related blindness.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results